Instituto Valenciano de Infertilidad
Valencia, 46015, Spain
NCT Number: NCT00802295
Our working hypothesis is that patients undergoing "in vitro" fertilization (IVF) with higher response to ovarian stimulation protocols recover a higher number of oocytes and, this elevated response could be translated into increased incidence of chromosomally abnormal embryos. Our objective is to develop a prospective study on healthy young donors, with a previous cycle with high ovarian response (>20 oocytes and/or E2 levels the day of the hCG injection >3000 pg/mL), but without developing mild or severe hyperstimulation syndrome. After signing a proper written consent, these donors would agree to undergo two subsequent stimulation cycles following two different protocols. In one cycle the stimulation pattern would be similar to the previous one, with elevated response and, in another cycle the amount of gonadotropins would be cut down in order to obtain lower ovarian response. Oocytes obtained in each cycle would be donated to anonymous recipients and after fertilization, embryo quality and chromosomal status of the resulting embryos would be evaluated. Preimplantation genetic diagnosis (PGD) will be performed on day-3 embryos and chromosomes 13, 15, 16, 17, 18, 21, 22, X and Y would be analyzed by fluorescence "in situ" hybridization (FISH).
Looking for future studies?
Notify Me18 year–29 year
Female
Interventional
Not applicable
Valencia, 46015, Spain
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of standard ovarian stimulation protocol
Time frame: three months
Time frame: three months
Instituto Valenciano de Infertilidad, IVI VALENCIA
Other
Influence of Ovarian Stimulation and Embryo Aneuploidy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05488236
Aneuploidy, Chromosome Aberrations
Lisbon, Portugal
View Trial DetailsNCT06801652
Aneuploidy, Blastocyst
Oradea, Bihor County, Romania
View Trial DetailsNCT04865367
Aneuploidy, Chromosome Aberrations
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT05936749
Aneuploidy, Chromosome Aberrations
View Trial Details